The global digital pathology market size surpassed at US$ 767.6 million in 2019 and is expected to grow at a CAGR of over 12.3% from 2019 to 2027.
The global digital pathology market size is projected to surpass around US$ 1.1 billion by 2027, rising awareness about digital pathology and increase in demand for advanced technology are the factors likely to boost the growth of digital pathology market. Moreover, high incidence and prevalence of cancer and other chronic diseases is poised to escalate the growth of digital pathology market.
Overview
Rising Adoption of Telepathology and Virtual Pathology to Drive Global Digital Pathology Market
Image Analysis Software Segment to Dominate Digital Pathology Market
Diagnostic Laboratories Segment Hold a Major Share of Global Digital Pathology Market
Diagnosis Segment to Dominate Global Digital Pathology Market
North America to Dominate Global Digital Pathology Market
Competitive Landscape
Market Segmentation
By Product Type
By End-user
By Applications
By Region
Report Scope
VRR’s report on the global digital pathology market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global digital pathology market for the period 2017–2027, considering 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global digital pathology market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global digital pathology market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global digital pathology market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global digital pathology market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global digital pathology market.
The report delves into the competitive landscape of the global digital pathology market. Key players operating in the global digital pathology market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global digital pathology market that have been profiled in this report.
Key Questions Answered in Global Digital Pathology Market Report
Research Methodology
A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global digital pathology market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary research sources referred to by analysts during the production of the global digital pathology market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the digital pathology market as primary methods.
These primary research respondents have provided exclusive information during interviews, which serves as a validation from the digital pathology market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global digital pathology market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global digital pathology more reliably and accurately.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Digital Pathology Market, By Product
7.1. Digital Pathology Market, by Product Type, 2021-2027
7.1.1. Software
7.1.1.1. Market Revenue and Forecast (2017-2027)
7.1.2. Device
7.1.2.1. Market Revenue and Forecast (2017-2027)
7.1.3. Storage System
7.1.3.1. Market Revenue and Forecast (2017-2027)
Chapter 8. Global Digital Pathology Market, By Application
8.1. Digital Pathology Market, by Application, 2021-2027
8.1.1. Drug Discovery & Development
8.1.1.1. Market Revenue and Forecast (2017-2027)
8.1.2. Academic research
8.1.2.1. Market Revenue and Forecast (2017-2027)
8.1.3. Disease Diagnosis
8.1.3.1. Market Revenue and Forecast (2017-2027)
Chapter 9. Global Digital Pathology Market, By End-use
9.1. Digital Pathology Market, by End-use, 2021-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2027)
9.1.2. Biotech & pharma companies
9.1.2.1. Market Revenue and Forecast (2017-2027)
9.1.3. Diagnostic Labs
9.1.3.1. Market Revenue and Forecast (2017-2027)
9.1.4. Academic & research institutes
9.1.4.1. Market Revenue and Forecast (2017-2027)
Chapter 10. Global Digital Pathology Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2017-2027)
10.1.2. Market Revenue and Forecast, by Application (2017-2027)
10.1.3. Market Revenue and Forecast, by End-use (2017-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2017-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2027)
10.1.4.3. Market Revenue and Forecast, by End-use (2017-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2017-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2017-2027)
10.1.5.3. Market Revenue and Forecast, by End-use (2017-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2017-2027)
10.2.2. Market Revenue and Forecast, by Application (2017-2027)
10.2.3. Market Revenue and Forecast, by End-use (2017-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2017-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2027)
10.2.4.3. Market Revenue and Forecast, by End-use (2017-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2017-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2027)
10.2.5.3. Market Revenue and Forecast, by End-use (2017-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2017-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2027)
10.2.6.3. Market Revenue and Forecast, by End-use (2017-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2017-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2017-2027)
10.2.7.3. Market Revenue and Forecast, by End-use (2017-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2017-2027)
10.3.2. Market Revenue and Forecast, by Application (2017-2027)
10.3.3. Market Revenue and Forecast, by End-use (2017-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2017-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2027)
10.3.4.3. Market Revenue and Forecast, by End-use (2017-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2017-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2027)
10.3.5.3. Market Revenue and Forecast, by End-use (2017-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2017-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2027)
10.3.6.3. Market Revenue and Forecast, by End-use (2017-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2017-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2017-2027)
10.3.7.3. Market Revenue and Forecast, by End-use (2017-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2017-2027)
10.4.2. Market Revenue and Forecast, by Application (2017-2027)
10.4.3. Market Revenue and Forecast, by End-use (2017-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2017-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2027)
10.4.4.3. Market Revenue and Forecast, by End-use (2017-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2017-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2027)
10.4.5.3. Market Revenue and Forecast, by End-use (2017-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2017-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2027)
10.4.6.3. Market Revenue and Forecast, by End-use (2017-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2017-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2017-2027)
10.4.7.3. Market Revenue and Forecast, by End-use (2017-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2017-2027)
10.5.2. Market Revenue and Forecast, by Application (2017-2027)
10.5.3. Market Revenue and Forecast, by End-use (2017-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2017-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2027)
10.5.4.3. Market Revenue and Forecast, by End-use (2017-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2017-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2017-2027)
10.5.5.3. Market Revenue and Forecast, by End-use (2017-2027)
Chapter 11. Company Profiles
11.1. Danaher
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Hamamatsu Photonics, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Koninklijke Philips N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Olympus Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F. Hoffmann-La Roche Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Mikroscan Technologies
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Inspirata, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Visiopharm A/S
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Huron Digital Pathology
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. 3DHISTECH Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. ContextVision AB.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms